Product Information
ENALAPRIL MALEATE 2.5 MG TAB is a generic product labeled by Amici Pharma, Inc, priced at $0.0625 per EA under NDC 69292054001. Its NADAC has been published 39 times since Jan 7, 2026.
FDA first approved this application on Aug 22, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Amici Pharma, IncNDC
69292054001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ENALAPRIL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA075483FDA Approved
8/22/2000
TE Code
AB
On Market Since
10/15/2025
Pharmacological Classes
Price Statistics
The NADAC for ENALAPRIL MALEATE 2.5 MG TAB has been published 39 times since Jan 7, 2026, and over the history we have for it it has declined 8.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0625 per EA |
|---|---|
| All-time high | $0.0747 (Feb 11, 2026) |
| All-time low | $0.0604 (Jul 22, 2026) |
| 52-week high | $0.0747 |
| 52-week low | $0.0604 |
| Median price | $0.0690 |
| Average price | $0.0677 |
| Largest weekly change | +9.3% (Jan 21, 2026) |
| Weeks tracked | 39 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amici Pharma, Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
enalapril maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENALAPRIL MALEATE 2.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ENALAPRIL MALEATE 2.5 MG TAB, manufactured by Amici Pharma, Inc, is $0.0625 per EA (NDC 69292054001), effective Sep 30, 2026.
How has the price of ENALAPRIL MALEATE 2.5 MG TAB changed over time?
Over the history we have for it, the NADAC for ENALAPRIL MALEATE 2.5 MG TAB has declined 8.6%. It has been tracked across 39 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for ENALAPRIL MALEATE 2.5 MG TAB?
Since Jan 7, 2026, the NADAC for ENALAPRIL MALEATE 2.5 MG TAB has ranged from a low of $0.0604 (Jul 22, 2026) to a high of $0.0747 (Feb 11, 2026), with a median of $0.0690 per EA.
Are there cheaper alternatives to ENALAPRIL MALEATE 2.5 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ENALAPRIL MALEATE 2.5 MG TAB, is $0.0607 per EA — about 3% below ENALAPRIL MALEATE 2.5 MG TAB.
Who manufactures ENALAPRIL MALEATE 2.5 MG TAB?
ENALAPRIL MALEATE 2.5 MG TAB (NDC 69292054001) is labeled by Amici Pharma, Inc, and CMS classifies it as a generic product.